Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Acta Medica Martiniana
Volume 20 (2020): Issue 2 (August 2020)
Open Access
Benefits of Therapeutic Drug Monitoring of First Line Antituberculosis Drugs
K Prso
K Prso
,
N Zidekova
N Zidekova
,
M Dohal
M Dohal
,
I Porvaznik
I Porvaznik
,
M Prso
M Prso
,
M Kertys
M Kertys
and
J Mokry
J Mokry
| Aug 20, 2020
Acta Medica Martiniana
Volume 20 (2020): Issue 2 (August 2020)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Aug 20, 2020
Page range:
45 - 55
Received:
Apr 29, 2020
Accepted:
May 28, 2020
DOI:
https://doi.org/10.2478/acm-2020-0006
Keywords
first-line antituberculosis drugs
,
therapeutic drug monitoring
,
isoniazid
,
rifampicin
,
ethambutol
,
pyrazinamide
© 2020 K Prso et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.